Why are hematologic cancers becoming a global research priorityBlood cancers such as leukemia, lymphoma, and multiple myeloma account for a significant portion of global cancer cases. Their complex nature, rapid progression, and resistance to standard therapies have made them a major focus for pharmaceutical innovation and clinical research. Today, the Hematologic Malignancies Market is...